Huntingtin reduction results in altered nuclear structure and heterochromatic instability

Area of Science:

• Neuroscience
• Genetics
• Cell Biology

Background:

• Huntington's disease (HD) is a fatal neurodegenerative disorder caused by a CAG repeat expansion in the huntingtin (HTT) gene.
• Wild-type huntingtin (wtHTT) is crucial for brain development and function.
• Current HD genetic therapies non-specifically reduce both mutant and wtHTT, necessitating an understanding of wtHTT reduction consequences.

Purpose of the Study:

• To investigate the cellular and subcellular effects of reducing wtHTT levels in adult primary hippocampal neurons.
• To characterize the impact of wtHTT reduction on nuclear structure, DNA organization, and signaling pathways.

Main Methods:

• Primary hippocampal neurons were treated with siRNA to reduce wtHTT expression.
• Conventional and super-resolution imaging techniques were employed for structural analysis.
• Changes in nuclear size, DNA decompaction, heterochromatin content, and pCREB signaling were assessed.

Main Results:

• wtHTT reduction led to a significant increase in nuclear size relative to the soma in hippocampal neurons.
• DNA decompaction and progressive loss of heterochromatin were observed following wtHTT knockdown.
• Biphasic changes in nuclear pCREB signaling were detected, while dendritic complexity and synaptic structures remained largely unaffected.

Conclusions:

• The cell nucleus is particularly vulnerable to wtHTT reduction in the context of Huntington's disease research.
• These findings highlight potential nuclear-specific mechanisms affected by huntingtin-lowering strategies.
• Understanding wtHTT's nuclear role is critical for developing targeted and safe HD therapies.